Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Integrated BioTherapeutics
company
About
AIntegrated BioTherapeutics is a focused on the discovery of novel vaccines and therapeutics for emerging infectious diseases.
- 11 - 50
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $6.60M
- Industries
- Biotechnology,Health Care,Pharmaceutical,Therapeutics
- Founded date
- Jan 1, 2005
- Number Of Employee
- 11 - 50
- Operating Status
- Active
A biotechnology company focused on the discovery of novel vaccines and therapeutics for emerging infectious diseases. It antiviral pipeline includes unique pan-filovirus antibody candidates, vaccines and a variety of other product candidates for emerging viruses.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$6.60M
Integrated BioTherapeutics has raised a total of
$6.60M
in funding over 2 rounds. Their latest funding was raised on
Aug 2, 2017 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 2, 2017 | Grant | $6.60M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Integrated BioTherapeutics is funded by 1 investors.
National Institutes of Health
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
National Institutes of Health
|
— | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
